Akèy › Sipwa › Kalifòni › Torrance
Etid klinik pou Sipwa nan Torrance, CA
9 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Torrance (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Peninsula Research Associates /ID# 282158, Rolling Hills Estates · 3 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- Peninsula Research Associates, Rolling Hills Estates · 3 mi lwen
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Ap rekriteFaz 3
- Research Site, Torrance
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- Peninsula Research Associates, Rolling Hills Estates · 3 mi lwen
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Peninsula Research Associates, Rolling Hills Estates · 3 mi lwen
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Rolling Hills Estates · 3 mi lwen
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Peninsula Research Associates, Rolling Hills Estates · 3 mi lwen
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Peninsula Research Associates, Rolling Hills Estates · 3 mi lwen
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, Rolling Hills Estates · 3 mi lwen
Etid Sipwa nan lòt vil
- San Antonio, TX34 etid
- Houston, TX33 etid
- Chicago, IL28 etid
- Orlando, FL27 etid
- Las Vegas, NV23 etid
- Miami, FL23 etid
- Atlanta, GA20 etid
- Dallas, TX20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan Torrance
- Kansè Poumon ki pa ti selil11 etid
- Obèsite9 etid
- Kansè nan tete9 etid
- Kansè vejik7 etid
- Kansè poumon7 etid
- Maladi kadyovaskilè7 etid
- Skizofreni6 etid
- Ensifizyans kadyak5 etid
- Ateroskleroz5 etid
- Kansè Metastatik4 etid
- Kansè kolorektal4 etid
- Maladi atè koronè4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.